191 related articles for article (PubMed ID: 21395445)
1. Accelerating vascularization in polycaprolactone scaffolds by endothelial progenitor cells.
Singh S; Wu BM; Dunn JC
Tissue Eng Part A; 2011 Jul; 17(13-14):1819-30. PubMed ID: 21395445
[TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of vasculogenic induction upon biaxial bioreactor stimulation of mesenchymal stem cells and endothelial progenitor cells cocultures in three-dimensional scaffolds under in vitro and in vivo paradigms for vascularized bone tissue engineering.
Liu Y; Teoh SH; Chong MS; Yeow CH; Kamm RD; Choolani M; Chan JK
Tissue Eng Part A; 2013 Apr; 19(7-8):893-904. PubMed ID: 23102089
[TBL] [Abstract][Full Text] [Related]
3. Electrospun scaffolds functionalized with heparin and vascular endothelial growth factor increase the proliferation of endothelial progenitor cells.
Braghirolli DI; Helfer VE; Chagastelles PC; Dalberto TP; Gamba D; Pranke P
Biomed Mater; 2017 Mar; 12(2):025003. PubMed ID: 28140340
[TBL] [Abstract][Full Text] [Related]
4. The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin.
Singh S; Wu BM; Dunn JC
Biomaterials; 2011 Mar; 32(8):2059-69. PubMed ID: 21147501
[TBL] [Abstract][Full Text] [Related]
5. Enhanced growth of endothelial precursor cells on PCG-matrix facilitates accelerated, fibrosis-free, wound healing: a diabetic mouse model.
Kanitkar M; Jaiswal A; Deshpande R; Bellare J; Kale VP
PLoS One; 2013; 8(7):e69960. PubMed ID: 23922871
[TBL] [Abstract][Full Text] [Related]
6. Enhancing angiogenesis alleviates hypoxia and improves engraftment of enteric cells in polycaprolactone scaffolds.
Singh S; Wu BM; Dunn JC
J Tissue Eng Regen Med; 2013 Dec; 7(12):925-33. PubMed ID: 22511397
[TBL] [Abstract][Full Text] [Related]
7. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds.
Fuchs S; Ghanaati S; Orth C; Barbeck M; Kolbe M; Hofmann A; Eblenkamp M; Gomes M; Reis RL; Kirkpatrick CJ
Biomaterials; 2009 Feb; 30(4):526-34. PubMed ID: 18977026
[TBL] [Abstract][Full Text] [Related]
8. Delivery of VEGF using collagen-coated polycaprolactone scaffolds stimulates angiogenesis.
Singh S; Wu BM; Dunn JC
J Biomed Mater Res A; 2012 Mar; 100(3):720-7. PubMed ID: 22213643
[TBL] [Abstract][Full Text] [Related]
9. Actin stabilization by jasplakinolide affects the function of bone marrow-derived late endothelial progenitor cells.
Zhang X; Cui X; Cheng L; Guan X; Li H; Li X; Cheng M
PLoS One; 2012; 7(11):e50899. PubMed ID: 23226422
[TBL] [Abstract][Full Text] [Related]
10. The role of endothelial progenitor cells in prevascularized bone tissue engineering: development of heterogeneous constructs.
Fedorovich NE; Haverslag RT; Dhert WJ; Alblas J
Tissue Eng Part A; 2010 Jul; 16(7):2355-67. PubMed ID: 20205515
[TBL] [Abstract][Full Text] [Related]
11. VEGF-mediated angiogenesis and vascularization of a fumarate-crosslinked polycaprolactone (PCLF) scaffold.
Wagner ER; Parry J; Dadsetan M; Bravo D; Riester SM; Van Wijnen AJ; Yaszemski MJ; Kakar S
Connect Tissue Res; 2018 Nov; 59(6):542-549. PubMed ID: 29513041
[TBL] [Abstract][Full Text] [Related]
12. Impaired in vivo vasculogenic potential of endothelial progenitor cells in comparison to human umbilical vein endothelial cells in a spheroid-based implantation model.
Finkenzeller G; Graner S; Kirkpatrick CJ; Fuchs S; Stark GB
Cell Prolif; 2009 Aug; 42(4):498-505. PubMed ID: 19489982
[TBL] [Abstract][Full Text] [Related]
13. The promotion of endothelial progenitor cells recruitment by nerve growth factors in tissue-engineered blood vessels.
Zeng W; Yuan W; Li L; Mi J; Xu S; Wen C; Zhou Z; Xiong J; Sun J; Ying D; Yang M; Li X; Zhu C
Biomaterials; 2010 Mar; 31(7):1636-45. PubMed ID: 20006381
[TBL] [Abstract][Full Text] [Related]
14. The role of single cell derived vascular resident endothelial progenitor cells in the enhancement of vascularization in scaffold-based skin regeneration.
Zhang Z; Ito WD; Hopfner U; Böhmert B; Kremer M; Reckhenrich AK; Harder Y; Lund N; Kruse C; Machens HG; Egaña JT
Biomaterials; 2011 Jun; 32(17):4109-17. PubMed ID: 21435711
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds.
Tan Q; Tang H; Hu J; Hu Y; Zhou X; Tao Y; Wu Z
Int J Nanomedicine; 2011; 6():929-42. PubMed ID: 21720505
[TBL] [Abstract][Full Text] [Related]
16. Enhanced vascularization in hybrid PCL/gelatin fibrous scaffolds with sustained release of VEGF.
Wang K; Chen X; Pan Y; Cui Y; Zhou X; Kong D; Zhao Q
Biomed Res Int; 2015; 2015():865076. PubMed ID: 25883978
[TBL] [Abstract][Full Text] [Related]
17. Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues.
Chiu LL; Radisic M
Biomaterials; 2010 Jan; 31(2):226-41. PubMed ID: 19800684
[TBL] [Abstract][Full Text] [Related]
18. Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6).
Smadja DM; Bièche I; Helley D; Laurendeau I; Simonin G; Muller L; Aiach M; Gaussem P
J Cell Mol Med; 2007; 11(5):1149-61. PubMed ID: 17979890
[TBL] [Abstract][Full Text] [Related]
19. Oxygen Tension-Controlled Matrices with Osteogenic and Vasculogenic Cells for Vascularized Bone Regeneration In Vivo.
Amini AR; Xu TO; Chidambaram RM; Nukavarapu SP
Tissue Eng Part A; 2016 Apr; 22(7-8):610-20. PubMed ID: 26914219
[TBL] [Abstract][Full Text] [Related]
20. Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering.
Chiu LL; Weisel RD; Li RK; Radisic M
J Tissue Eng Regen Med; 2011 Jan; 5(1):69-84. PubMed ID: 20717888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
